These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Large-scale profiling of microRNAs for The Cancer Genome Atlas. Chu A; Robertson G; Brooks D; Mungall AJ; Birol I; Coope R; Ma Y; Jones S; Marra MA Nucleic Acids Res; 2016 Jan; 44(1):e3. PubMed ID: 26271990 [TBL] [Abstract][Full Text] [Related]
24. Gene signatures developed from patient tumor explants grown in nude mice to predict tumor response to 11 cytotoxic drugs. Fiebig HH; Schüler J; Bausch N; Hofmann M; Metz T; Korrat A Cancer Genomics Proteomics; 2007; 4(3):197-209. PubMed ID: 17878523 [TBL] [Abstract][Full Text] [Related]
25. Evaluation of hierarchical models for integrative genomic analyses. Denis M; Tadesse MG Bioinformatics; 2016 Mar; 32(5):738-46. PubMed ID: 26545823 [TBL] [Abstract][Full Text] [Related]
26. Molecular analysis of urothelial cancer cell lines for modeling tumor biology and drug response. Nickerson ML; Witte N; Im KM; Turan S; Owens C; Misner K; Tsang SX; Cai Z; Wu S; Dean M; Costello JC; Theodorescu D Oncogene; 2017 Jan; 36(1):35-46. PubMed ID: 27270441 [TBL] [Abstract][Full Text] [Related]
27. Integrating full spectrum of sequence features into predicting functional microRNA-mRNA interactions. Wang Z; Xu W; Liu Y Bioinformatics; 2015 Nov; 31(21):3529-36. PubMed ID: 26130578 [TBL] [Abstract][Full Text] [Related]
28. A link prediction approach to cancer drug sensitivity prediction. Turki T; Wei Z BMC Syst Biol; 2017 Oct; 11(Suppl 5):94. PubMed ID: 28984192 [TBL] [Abstract][Full Text] [Related]
29. Data Mining Approaches for Genomic Biomarker Development: Applications Using Drug Screening Data from the Cancer Genome Project and the Cancer Cell Line Encyclopedia. Covell DG PLoS One; 2015; 10(7):e0127433. PubMed ID: 26132924 [TBL] [Abstract][Full Text] [Related]
30. Predictive genomics: a cancer hallmark network framework for predicting tumor clinical phenotypes using genome sequencing data. Wang E; Zaman N; Mcgee S; Milanese JS; Masoudi-Nejad A; O'Connor-McCourt M Semin Cancer Biol; 2015 Feb; 30():4-12. PubMed ID: 24747696 [TBL] [Abstract][Full Text] [Related]
31. Whole-Exome Sequencing of Metastatic Cancer and Biomarkers of Treatment Response. Beltran H; Eng K; Mosquera JM; Sigaras A; Romanel A; Rennert H; Kossai M; Pauli C; Faltas B; Fontugne J; Park K; Banfelder J; Prandi D; Madhukar N; Zhang T; Padilla J; Greco N; McNary TJ; Herrscher E; Wilkes D; MacDonald TY; Xue H; Vacic V; Emde AK; Oschwald D; Tan AY; Chen Z; Collins C; Gleave ME; Wang Y; Chakravarty D; Schiffman M; Kim R; Campagne F; Robinson BD; Nanus DM; Tagawa ST; Xiang JZ; Smogorzewska A; Demichelis F; Rickman DS; Sboner A; Elemento O; Rubin MA JAMA Oncol; 2015 Jul; 1(4):466-74. PubMed ID: 26181256 [TBL] [Abstract][Full Text] [Related]
32. A Lasso regression model for the construction of microRNA-target regulatory networks. Lu Y; Zhou Y; Qu W; Deng M; Zhang C Bioinformatics; 2011 Sep; 27(17):2406-13. PubMed ID: 21743061 [TBL] [Abstract][Full Text] [Related]
33. Predicting censored survival data based on the interactions between meta-dimensional omics data in breast cancer. Kim D; Li R; Dudek SM; Ritchie MD J Biomed Inform; 2015 Aug; 56():220-8. PubMed ID: 26048077 [TBL] [Abstract][Full Text] [Related]
34. Identifying anti-cancer drug response related genes using an integrative analysis of transcriptomic and genomic variations with cell line-based drug perturbations. Sun Y; Zhang W; Chen Y; Ma Q; Wei J; Liu Q Oncotarget; 2016 Feb; 7(8):9404-19. PubMed ID: 26824188 [TBL] [Abstract][Full Text] [Related]
35. GDISC: a web portal for integrative analysis of gene-drug interaction for survival in cancer. Spainhour JCG; Lim J; Qiu P Bioinformatics; 2017 May; 33(9):1426-1428. PubMed ID: 28453687 [TBL] [Abstract][Full Text] [Related]